Randox - Plasminogen Activator Inhibitor 1 (PAI-1) (Western Blot Control)

• Catalog Number: RCP9090
• Category: Proteins
• Description: PAI-1 is a serine protease inhibitor, which can exist, either in an active inhibitory conformation or in an inactive or latent conformation. PAI-1 is produced mainly by the endothelium but is also secreted by other tissue types including adipose tissue. PAI-1 is the principal inhibitor of tissue plasminogen activator and urokinase, therefore inhibiting fibrinolysis. Increased levels of PAI-1 have been linked with various conditions including cardiovascular disease, thrombosis, insulin resistance and obesity.
• Tag: N terminal containing a HIS tag
• Form/Appearance: Liquid. Supplied in 1x Laemmli Buffer (25mM Tris-HCl pH 6.8, 50mM DTT, 1% (w/v) SDS, 0.1% (w/v) Bromophenol Blue, 2.5% Glycerol).
• Purity: > 95 %, by SDS-PAGE under reducing conditions
• MW: 47.27 kDa
• UniProt ID: P05121
• Protein Length: Val24-Pro402
• Source: E.coli -derived human recombinant protein
• Expression System: E.coli
• Storage: at -20 °C
• Buffer/Preservatives: 1X Laemmli buffer
• Alternative names: Plasminogen activator inhibitor 1; Endothelial pla
• Note: For research use only
• Application notes: ELISA, Western Blotting, etc.
• Expiration Date: 6 months from date of receipt.